Literature DB >> 17657863

Relationship between hyperuricemia and metabolic syndrome.

Li-ying Chen1, Wen-hua Zhu, Zhou-wen Chen, Hong-lei Dai, Jing-jing Ren, Jian-hua Chen, Lei-qian Chen, Li-zheng Fang.   

Abstract

OBJECTIVE: To investigate the relationship between metabolic syndrome and hyperuricemia.
METHODS: A total of 2 374 subjects who received health examination in our hospital from Jan. 2004 to Dec. 2006 were enrolled in our study. Hyperuricemia is defined as >or=7 mg/dl (in men) or >or=6.0 mg/dl (in women). Metabolic syndrome was defined using AHA/NHLBI (American Heart Association/National Heart, Lung, and Blood Institute) criteria.
RESULTS: (1) The overall prevalence of hyperuricemia was 13.10%. The condition was more common in men than in women (19.07% vs 3.42%). (2) Among men, uric acid concentration is statistically significantly positively correlated with waist circumference, blood pressure, and triglyceride. Uric acid is negatively correlated with serum high-density lipoprotein-cholesterol (HDL-C). Uric acid concentration is most strongly correlated with serum triglyceride (r=0.379) and waist circumference (r=0.297). Among women, statistically significant positive correlations were noted for the serum uric acid concentrations with waist circumference, triglyceride and fasting plasma glucose. Serum triglyceride (r=0.329) and waist circumference (r=0.234) are most strongly correlated with uric acid concentrations. (3) Men with hyperuricemia had a 1.634-fold increased risk of metabolic syndrome as compared with those without hyperuricemia [odds ratio (OR)=1.634, P=0.000]. Women with hyperuricemia had a 1.626-fold increased risk of metabolic syndrome (OR=1.626, P=0.000) as compared with those without hyperuricemia.
CONCLUSION: Hyperuricemia is prevalent among Chinese population. Additionally, serum uric acid is positively associated with metabolic syndrome.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17657863      PMCID: PMC1934956          DOI: 10.1631/jzus.2007.B0593

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN: 1673-1581            Impact factor:   3.066


  22 in total

1.  Reduction of serum uric acid by hormone replacement therapy in postmenopausal women with hyperuricaemia.

Authors:  H Sumino; S Ichikawa; T Kanda; T Nakamura; T Sakamaki
Journal:  Lancet       Date:  1999-08-21       Impact factor: 79.321

Review 2.  Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement.

Authors:  Scott M Grundy; James I Cleeman; Stephen R Daniels; Karen A Donato; Robert H Eckel; Barry A Franklin; David J Gordon; Ronald M Krauss; Peter J Savage; Sidney C Smith; John A Spertus; Fernando Costa
Journal:  Circulation       Date:  2005-09-12       Impact factor: 29.690

3.  Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome.

Authors:  Tae Woo Yoo; Ki Chul Sung; Hun Sub Shin; Byung Jin Kim; Bum Soo Kim; Jin Ho Kang; Man Ho Lee; Jung Ro Park; Hyang Kim; Eun Jung Rhee; Won Young Lee; Sun Woo Kim; Seung Ho Ryu; Dong Geuk Keum
Journal:  Circ J       Date:  2005-08       Impact factor: 2.993

4.  Serum leptin is associated with serum uric acid concentrations in humans.

Authors:  B Fruehwald-Schultes; A Peters; W Kern; J Beyer; A Pfützner
Journal:  Metabolism       Date:  1999-06       Impact factor: 8.694

5.  Isolated low HDL cholesterol: an insulin-resistant state only in the presence of fasting hypertriglyceridemia.

Authors:  E S Tai; S C Emmanuel; S K Chew; B Y Tan; C E Tan
Journal:  Diabetes       Date:  1999-05       Impact factor: 9.461

Review 6.  [Serum uric acid--a cardiovasular risk factor?].

Authors:  M Alderman; J S Redfern
Journal:  Ther Umsch       Date:  2004-09

7.  Effect of visceral fat accumulation on uric acid metabolism in male obese subjects: visceral fat obesity is linked more closely to overproduction of uric acid than subcutaneous fat obesity.

Authors:  F Matsuura; S Yamashita; T Nakamura; M Nishida; S Nozaki; T Funahashi; Y Matsuzawa
Journal:  Metabolism       Date:  1998-08       Impact factor: 8.694

Review 8.  The glycolytic pathway to coronary heart disease: a hypothesis.

Authors:  F Leyva; C S Wingrove; I F Godsland; J C Stevenson
Journal:  Metabolism       Date:  1998-06       Impact factor: 8.694

9.  The prevalence of metabolic syndrome in patients with gout: a multicenter study.

Authors:  Young Hee Rho; Seong Jae Choi; Young Ho Lee; Jong Dae Ji; Kyung Mook Choi; Sei Hyun Baik; Seung-hie Chung; Chae-Gi Kim; Jung-Yoon Choe; Sung Won Lee; Won Tae Chung; Gwan Gyu Song
Journal:  J Korean Med Sci       Date:  2005-12       Impact factor: 2.153

10.  Clustering of dyslipidemia, hyperuricemia, diabetes, and hypertension and its association with fasting insulin and central and overall obesity in a general population. Atherosclerosis Risk in Communities Study Investigators.

Authors:  M I Schmidt; R L Watson; B B Duncan; P Metcalf; F L Brancati; A R Sharrett; C E Davis; G Heiss
Journal:  Metabolism       Date:  1996-06       Impact factor: 8.694

View more
  48 in total

1.  Effects of serum uric acid levels on the arginase pathway in women with metabolic syndrome.

Authors:  S Uslu; E Ozcelik; N Kebapci; H E Temel; F Demirci; B Ergun; C Demirustu
Journal:  Ir J Med Sci       Date:  2015-08-02       Impact factor: 1.568

Review 2.  Dietary and commercialized fructose: Sweet or sour?

Authors:  Aslihan Yerlikaya; Tuncay Dagel; Christopher King; Masanari Kuwabara; Miguel A Lanaspa; Ana Andres-Hernando; Adrian Covic; Jacek Manitius; Alan A Sag; Mehmet Kanbay
Journal:  Int Urol Nephrol       Date:  2017-02-16       Impact factor: 2.370

3.  Relationship between hyperuricemia and dietary risk factors in Chinese adults: a cross-sectional study.

Authors:  Xue Li; Peige Song; Junping Li; Peiyu Wang; Guowei Li
Journal:  Rheumatol Int       Date:  2015-07-05       Impact factor: 2.631

4.  Protective role of α-lipoic acid in hyperuricemia-induced endothelial dysfunction.

Authors:  Hui Zou; Huan Wang; Tongmei Liu; Xiaojie Li; Xiaoduo Zhu; Zheng Wang
Journal:  Exp Ther Med       Date:  2017-04-18       Impact factor: 2.447

5.  Long-term high fructose and saturated fat diet affects plasma fatty acid profile in rats.

Authors:  Fabrice Tranchida; Léopold Tchiakpe; Zo Rakotoniaina; Valérie Deyris; Olivier Ravion; Abel Hiol
Journal:  J Zhejiang Univ Sci B       Date:  2012-04       Impact factor: 3.066

6.  Relevance of uric Acid in progression of type 2 diabetes mellitus.

Authors:  Adlija Causevic; Sabina Semiz; Amra Macic Dzankovic; Bakira Cico; Tanja Dujic; Maja Malenica; Tamer Bego
Journal:  Bosn J Basic Med Sci       Date:  2010-02       Impact factor: 3.363

Review 7.  Potential role of uric acid in metabolic syndrome, hypertension, kidney injury, and cardiovascular diseases: is it time for reappraisal?

Authors:  Zohreh Soltani; Kashaf Rasheed; Daniel R Kapusta; Efrain Reisin
Journal:  Curr Hypertens Rep       Date:  2013-06       Impact factor: 5.369

8.  Hyperuricaemia and the metabolic syndrome in type 2 DM.

Authors:  Anthonia O Ogbera; Alfred O Azenabor
Journal:  Diabetol Metab Syndr       Date:  2010-04-20       Impact factor: 3.320

9.  Blood lipid profile and BMI-Z-score in adolescents with hyperuricemia.

Authors:  M J Stelmach; N Wasilewska; L I Wicklund-Liland; A Wasilewska
Journal:  Ir J Med Sci       Date:  2014-05-30       Impact factor: 1.568

10.  The causal role of elevated uric acid and waist circumference on the risk of metabolic syndrome components.

Authors:  Mahantesh I Biradar; Kuang-Mao Chiang; Hsin-Chou Yang; Yen-Tsung Huang; Wen-Harn Pan
Journal:  Int J Obes (Lond)       Date:  2019-11-21       Impact factor: 5.095

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.